跳至主要内容
临床试验/ITMCTR1900002647
ITMCTR1900002647尚未招募1 期

The efficiency of continuous intrafemoral perfusion of PRP combine with the therapy of promoting blood circulation to C1 type femoral head necrosis preservation

The First Affiliated Hospital of Guangzhou University of Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 55(—)
性别
All

入选标准

  • (1) Aged 18-55 years, male or female, non-traumatic femoral head necrosis;
  • (2) X-ray of the hip joint is showing C1 type femoral head necrosis;
  • (3) Patients with ARCO stage of ONFH who are stage II with significant pain and patients with stage IIIA with pain or limited mobility;
  • (4) The affected femoral head did not collapse or collapsed less than 4mm, the joint space was not significantly narrow, and the head-to-head matching relationship was good;
  • (5) The patient agrees to participate in the trial and sign an informed consent form.

排除标准

  • (1) Patients with other diseases that affect the progression of ONFH (such as major diseases of heart, lung, liver and kidney system, nephrotic syndrome, systemic lupus erythematosus, etc. still need to take hormones) and are in active period;
  • (2) Subjects suffering from hip or surrounding fractures, infections, tumors, etc. during the trial;
  • (3) Subjects with serious adverse reactions during the test;
  • (4) The investigator believes that it is not appropriate to continue to participate in the subjects of this clinical trial.

研究者

发起方
The First Affiliated Hospital of Guangzhou University of Chinese Medicine

相似试验